Replimune (REPL) Capital Leases (2019 - 2025)
Replimune's (REPL) quarterly Capital Leases came in at $22.1 million in Q4 2025, down 3.42% year-on-year from $22.9 million in Q4 2024, and down 0.96% quarter-over-quarter from $22.3 million in Q3 2025.
Replimune (REPL) Capital Leases (2019 - 2025) Analysis & Trends
Replimune has disclosed Capital Leases across 7 years of filings, most recently posting $22.1 million for Q4 2025.
- Capital Leases for Q4 2025 came in at $22.1 million, down 3.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $22.1 million (down 3.42% YoY), and the FY2025 annual result was $22.7 million, down 2.91% from the prior year.
- Capital Leases came in at $22.1 million for Q4 2025 at Replimune, down from $22.3 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $24.7 million in Q1 2021 to a low of $22.1 million in Q4 2025.
- The 5-year median for Capital Leases is $23.8 million (2023), against an average of $23.7 million.
- Across the five-year window, Capital Leases fell 0.89% in 2021 and dropped 3.42% in 2025, its largest moves.
- Replimune's Capital Leases stood at $24.5 million in 2021, then declined by 1.69% to $24.1 million in 2022, then decreased by 2.18% to $23.6 million in 2023, then dropped by 2.75% to $22.9 million in 2024, then declined by 3.42% to $22.1 million in 2025.
- The last three Capital Leases figures came in at $22.1 million (Q4 2025), $22.3 million (Q3 2025), and $22.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.13 Mn |
| Sep 30, 2025 | 22.34 Mn |
| Jun 30, 2025 | 22.54 Mn |
| Mar 31, 2025 | 22.73 Mn |
| Dec 31, 2024 | 22.91 Mn |
| Sep 30, 2024 | 23.09 Mn |
| Jun 30, 2024 | 23.26 Mn |
| Mar 31, 2024 | 23.41 Mn |
| Dec 31, 2023 | 23.56 Mn |
| Sep 30, 2023 | 23.71 Mn |
| Jun 30, 2023 | 23.84 Mn |
| Mar 31, 2023 | 23.97 Mn |
| Dec 31, 2022 | 24.09 Mn |
| Sep 30, 2022 | 24.21 Mn |
| Jun 30, 2022 | 24.31 Mn |
| Mar 31, 2022 | 24.41 Mn |
| Dec 31, 2021 | 24.50 Mn |
| Sep 30, 2021 | 24.59 Mn |
| Jun 30, 2021 | 24.67 Mn |
| Mar 31, 2021 | 24.75 Mn |